BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37461434)

  • 41. Spectral Analysis Based on Hemodynamic Habitat Imaging Predicts Isocitrate Dehydrogenase Status and Prognosis in High-Grade Glioma.
    Qiao J; Wu H; Liu J; Kang H; Wang S; Fang J; Zhang J; Zhang W
    World Neurosurg; 2023 Jul; 175():e520-e530. PubMed ID: 37028478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
    Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
    Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.
    Malmer B; Henriksson R; Grönberg H
    Neuroepidemiology; 2002; 21(6):279-86. PubMed ID: 12411730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoexponential, biexponential and stretched exponential models of diffusion weighted magnetic resonance imaging in glioma in relation to histopathologic grade and Ki-67 labeling index using high B values.
    Chaudhary N; Zhang G; Li S; Zhu W
    Am J Transl Res; 2021; 13(11):12480-12494. PubMed ID: 34956467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of
    Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma.
    Zhang H; Zhang L; Tang Y; Wang C; Chen Y; Shu J; Zhang K
    Biomed Pharmacother; 2019 Oct; 118():109215. PubMed ID: 31545245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
    Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
    Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IDH1
    Han X; Zhou H; Sun W; Hou L; Wang Y; Wang H; Lv Z; Xue X
    Sci Rep; 2023 Nov; 13(1):19659. PubMed ID: 37952042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways.
    Wang Z; Zhang J; Zhang H; Dai Z; Liang X; Li S; Peng R; Zhang X; Liu F; Liu Z; Yang K; Cheng Q
    Front Cell Dev Biol; 2022; 10():740822. PubMed ID: 35252165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
    Bady P; Kurscheid S; Delorenzi M; Gorlia T; van den Bent MJ; Hoang-Xuan K; Vauléon É; Gijtenbeek A; Enting R; Thiessen B; Chinot O; Dhermain F; Brandes AA; Reijneveld JC; Marosi C; Taphoorn MJB; Wick W; von Deimling A; French P; Stupp R; Baumert BG; Hegi ME
    Acta Neuropathol; 2018 Apr; 135(4):601-615. PubMed ID: 29368212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.
    Zhang Y; Xie Y; He L; Tang J; He Q; Cao Q; Cui L; Guo W; Hua K; Dimberg A; Wang L; Zhang L
    Cell Oncol (Dordr); 2021 Feb; 44(1):193-204. PubMed ID: 32915415
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
    Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
    J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
    Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
    J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
    Binder H; Willscher E; Loeffler-Wirth H; Hopp L; Jones DTW; Pfister SM; Kreuz M; Gramatzki D; Fortenbacher E; Hentschel B; Tatagiba M; Herrlinger U; Vatter H; Matschke J; Westphal M; Krex D; Schackert G; Tonn JC; Schlegel U; Steiger HJ; Wick W; Weber RG; Weller M; Loeffler M
    Acta Neuropathol Commun; 2019 Apr; 7(1):59. PubMed ID: 31023364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glioma Grade Discrimination with MR Diffusion Kurtosis Imaging: A Meta-Analysis of Diagnostic Accuracy.
    Falk Delgado A; Nilsson M; van Westen D; Falk Delgado A
    Radiology; 2018 Apr; 287(1):119-127. PubMed ID: 29206593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux.
    Cj P; Hv E; Vijayakurup V; R Menon G; Nair S; Gopala S
    Pathol Oncol Res; 2019 Jan; 25(1):137-148. PubMed ID: 29022195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.
    Zhang K; Liu X; Li G; Chang X; Li S; Chen J; Zhao Z; Wang J; Jiang T; Chai R
    Cancer Biol Med; 2022 Nov; 19(10):1460-76. PubMed ID: 36350010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Texture analysis of apparent diffusion coefficient (ADC) map for glioma grading: Analysis of whole tumoral and peri-tumoral tissue.
    Soliman RK; Essa AA; Elhakeem AAS; Gamal SA; Zaitoun MMA
    Diagn Interv Imaging; 2021 May; 102(5):287-295. PubMed ID: 33419692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma.
    Liu S; Liu Y; Li G; Feng J; Chen L; Qiu X
    Chin Neurosurg J; 2021 Apr; 7(1):22. PubMed ID: 33795023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.